| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |